These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38873667)

  • 1. Increased FGF2 expression promotes immune cell infiltration and correlates with an unfavorable prognosis in thyroid cancer.
    Chen H; Du X
    Heliyon; 2024 Jun; 10(11):e32272. PubMed ID: 38873667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA H19 is a potential biomarker and correlated with immune infiltration in thyroid carcinoma.
    Sahin Y
    Clin Exp Med; 2023 Jul; 23(3):841-851. PubMed ID: 35810257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic analysis of the prognosis and immune infiltration of E2Fs in thyroid carcinoma.
    Fu X; Zhou X; Ji F; He Q; Qiu X
    Front Genet; 2023; 14():1215984. PubMed ID: 37560385
    [No Abstract]   [Full Text] [Related]  

  • 4. HSPA5 is a prognostic biomarker correlated with immune infiltrates in thyroid carcinoma.
    Dong W; Du D; Huang H
    Endokrynol Pol; 2022; 73(4):680-689. PubMed ID: 36059163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prognostic Value of PERK in Cancer and Its Relationship With Immune Cell Infiltration.
    Wang P; Han L; Yu M; Cao Z; Li X; Shao Y; Zhu G
    Front Mol Biosci; 2021; 8():648752. PubMed ID: 33937330
    [No Abstract]   [Full Text] [Related]  

  • 6. Comprehensive analysis of BTNL9 as a prognostic biomarker correlated with immune infiltrations in thyroid cancer.
    Zhang L; Yu S; Hong S; Xiao X; Liao Z; Li Y; Xiao H
    BMC Med Genomics; 2023 Oct; 16(1):234. PubMed ID: 37798795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploration and validation of key genes associated with early lymph node metastasis in thyroid carcinoma using weighted gene co-expression network analysis and machine learning.
    Liu Y; Yin Z; Wang Y; Chen H
    Front Endocrinol (Lausanne); 2023; 14():1247709. PubMed ID: 38144565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated PDE4C level serves as a candidate diagnostic biomarker and correlates with poor survival in thyroid carcinoma.
    Wang Y; Zhang Y; Li Y; Huang J
    Sci Rep; 2024 Mar; 14(1):6813. PubMed ID: 38514754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinformatics analysis for the identification of Sprouty-related EVH1 domain-containing protein 3 expression and its clinical significance in thyroid carcinoma.
    Zhang X; Meng X; Wang P; Luan C; Wang H
    Sci Rep; 2024 Feb; 14(1):4549. PubMed ID: 38402263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Key molecules associated with thyroid carcinoma prognosis: A study based on transcriptome sequencing and GEO datasets.
    Bai M; Ke S; Yu H; Xu Y; Yu Y; Lu S; Wang C; Huang J; Ma Y; Dai W; Wu Y
    Front Immunol; 2022; 13():964891. PubMed ID: 36059514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NEFM DNA methylation correlates with immune infiltration and survival in breast cancer.
    Li D; Zhao W; Zhang X; Lv H; Li C; Sun L
    Clin Epigenetics; 2021 May; 13(1):112. PubMed ID: 34001208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
    Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
    Front Immunol; 2019; 10():6. PubMed ID: 30761122
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of LAMA4 on Prognosis and Its Correlation with Immune Infiltration in Gastric Cancer.
    Wang M; Li C; Liu Y; Wang Z
    Biomed Res Int; 2021; 2021():6428873. PubMed ID: 34414238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of zinc finger CCHC-type superfamily proteins in thyroid carcinoma and their associations with tumor immunity.
    Yin Y; Chen J; Chen Q; He H; Zhu N; Xia P; Yu C; Meng L
    Thyroid Res; 2023 Oct; 16(1):42. PubMed ID: 37848968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid cancer prognostic biomarker ARL4A and its relationship with immune infiltration.
    Han X; Liao J; Zhou Y; Hu X; Wu H
    Int J Clin Exp Pathol; 2024; 17(4):108-120. PubMed ID: 38716351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FN1, a reliable prognostic biomarker for thyroid cancer, is associated with tumor immunity and an unfavorable prognosis.
    Pan H; Luo Z; Lin F; Zhang J; Xiong T; Hong Y; Sun B; Yang Y
    Oncol Lett; 2024 Nov; 28(5):510. PubMed ID: 39268167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
    Sun K; Chen RX; Li JZ; Luo ZX
    Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of m6A-associated LncRNAs as predict factors for the immune infiltration and prognosis of thyroid cancer.
    Su Y; Xu B; Li J; Shen Q; Lei Z; Ma M; Zhang F; Hu T
    Ann Med; 2023 Dec; 55(1):1298-1316. PubMed ID: 36974635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value and immunological role of BAIAP2L2 in liver hepatocellular carcinoma: A pan-cancer analysis.
    Han X; Long W; Liu Y; Xu J
    Front Surg; 2022; 9():985034. PubMed ID: 36338652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative Multi-Omics Analysis of Identified Ferroptosis-Marker RPL8 as a Candidate Oncogene Correlates with Poor Prognosis and Immune Infiltration in Liver Cancer.
    Fan S; Zhang S; Kong D; Wang H; Shi Y; Wang Z; Zheng H
    Comb Chem High Throughput Screen; 2023; 26(7):1298-1310. PubMed ID: 36017842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.